Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Iron DeficiencyHeart FailureChronic Kidney Disease
Interventions
DRUG

Iron Sucrose

At each visit, the patient lay on a stretcher and underwent a vein cannulation in the forearm with a commercial canula no. 16, which was connected to IV tubing that was connected to a bag contained 200 ml isotonic saline solution 0.9% plus 200 mg of Iron Sucrose. Each infusion was administered throughout 60 min. This scheme was followed for 5 consecutive weeks.

DRUG

Placebo

At each visit, the patient lay on a stretcher and underwent a vein cannulation in the forearm with a commercial canula no. 16, which was connected to IV tubing that was connected to a bag of isotonic saline solution 0.9% (200 ml). Each infusion was administered throughout 60 min. This scheme was followed for 5 consecutive weeks.

Trial Locations (1)

1118

Hospital Aleman, Buenos Aires

All Listed Sponsors
lead

Hospital Aleman

OTHER

NCT02392910 - Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron. | Biotech Hunter | Biotech Hunter